Dr. Salman Farhat, MD

Dr. Farhat practices at Ascension St Vincents Clay County Hospital in Middleburg, Florida.

Dr. Farhat's NPI, 1356780274, was assigned on June 25, 2013. Dr. Farhat graduated from King Edward Medical University in 2010. Dr. Farhat holds Florida license ME135998.

Dr. Farhat's primary practice is Ascension St Vincents Clay County Hospital, at 1670 St Vincents Way, Middleburg, FL 32068 in Clay County. The practice phone is (904) 308-8446.

Dr. Farhat's primary practice is Ascension St Vincents Clay County Hospital in Middleburg, Florida. Dr. Farhat is also affiliated with Ascension St. Vincent's Clay County. The medical group on file is St. Vincent's Healthcare. Dmand AI also links Dr. Farhat to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhat practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Farhat's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Farhat is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Farhat's licenses on file in 5 states: Florida, Missouri, Minnesota, New Jersey and Pennsylvania.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease and heart failure among the conditions Dr. Farhat treats.

CMS data shows 1,020 Medicare services from Dr. Farhat across 17 procedure codes in 2024, for 403 Medicare patients. Medicare paid $111,960 for them.

CMS counts 403 Medicare patients who saw Dr. Farhat in 2024. The largest group is 75 to 84, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farhat's median patient age at 73, with 53% women.

In 2024, Dr. Farhat wrote 1,899 Medicare Part D claims for 329 patients. 81% of them were for generic drugs. CMS names the drug for 1,731 of them, across 30 drugs with 11 or more claims each, at $302,401 in total drug cost. In 2023, CMS named 930 claims across 23 drugs.

Dr. Farhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farhat as offering telehealth. CMS counts 40 procedures of coronary angioplasty and stenting by Dr. Farhat, more than 76% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Farhat, published from 2014 to 2021. 2014 was the busiest year, with 2. The most frequent topics are Percutaneous Coronary Intervention, Stroke and Transcatheter Aortic Valve Replacement. Dr. Farhat's most frequent co-authors are Abdallah El Sabbagh, MD, Rajiv Gulati, MD and Peter M. Pollak, MD.

CMS Open Payments shows 88 general payments to Dr. Farhat from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Abbott Laboratories paid the most, $1,871.

Dr. Farhat graduated from King Edward Medical University in 2010.

Dr. Farhat is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.